New diabetes drug hits UK market

[Northerner]

Patients with type II diabetes now have access to a new option for managing their blood glucose levels with the launch of Boehringer Ingelheim/Eli Lilly's new combination drug Jentadueto in the UK this week.

Jentadueto combines two antiglycaemic therapies - the veteran drug metformin with the dipeptidyl peptidase (DPP)-IV inhibitor Trajenta (linagliptin) - in a single pill, providing the opportunity for better treatment compliance by reducing the pill burden for patients.

http://www.pharmatimes.com/Article/12-10-16/New_diabetes_drug_hits_UK_market.aspx

 

[Pumper_Sue]

Providing test strips and education would be a lot cheaper and a better results. 🙄

 

[Mark T]

So not only is it that we inflicted it on ourselves by being too lazy and eating too much... we are also too lazy to take pills 🙄